Manhattan U.S. Attorney Announces Charges Against 10 Individuals In Multi-Million Dollar Internet Pharmacy Fraud Scheme Two Pharmacists Were Allegedly Paid At Least $13 Million By Bogus Online Pharmacy Operators For Filling Invalid Prescriptions Issued By
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Atlanta
        • Atlanta Leadership
        • Atlanta Contacts
      • Caribbean
        • Caribbean Leadership
        • Caribbean Contacts
      • Chicago
        • Chicago Leadership
        • Chicago Contacts
      • Dallas
        • Dallas Leadership
        • Dallas Contacts
      • Detroit
        • Detroit Leadership
        • Detroit Contacts
      • El Paso
        • El Paso Contacts
      • Headquarters
      • Houston
        • Houston Leadership
        • Houston Contacts
      • Los Angeles
        • Los Angeles Leadership
        • Los Angeles Contacts
      • Louisville
        • Louisville Leadership
        • Louisville Contacts
      • Miami
        • Miami Leadership
        • Miami Contacts
      • New England
        • New England Leadership
        • New England Contacts
      • New Jersey
        • New Jersey Leadership
        • New Jersey Contacts
      • New Orleans
        • New Orleans Leadership
        • New Orleans Contacts
      • New York
        • New York Leadership
        • New York Contacts
      • Omaha
        • Omaha Leadership
        • Omaha Contacts
      • Philadelphia
        • Philadelphia Leadership
        • Philadelphia Contacts
      • Phoenix
        • Phoenix Leadership
        • Phoenix Contacts
      • Rocky Mountain
        • Rocky Mountain Contacts
      • San Diego
        • San Diego Leadership
        • San Diego Contacts
      • San Francisco
        • San Francisco Leadership
        • San Francisco Contacts
      • Seattle
        • Seattle Leadership
        • Seattle Contacts
      • St. Louis
        • St. Louis Leadership
        • St. Louis Contacts
      • Washington, DC
        • Washington Leadership
        • Washington Contacts
    • DEA Museum
    • Foreign Divisions
      • Africa
      • Andean
      • Caribbean
      • Europe
      • Asia Pacific
        • Asia Pacific Leadership
      • Middle East
      • North and Central America
      • Southern Cone
    • Operational Divisions
      • Aviation Division
      • Diversion Control Division
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
        • Mission
        • Services
        • Contacts
      • Forensic Sciences
        • Computer Forensics Program
        • Environmental Management
        • Laboratories
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
        • State and Local Task Forces
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
      • Special Agent Job Announcements
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • How to Apply
      • Employment Requirements
      • Equal Opportunity Employer
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
  • Resources
    • Recovery Resources
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Foreign Divisions
    • Operational Divisions
    • Wall of Honor
    • Contact Us
  • What We Do
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • How to Apply
  • Resources
    • Recovery Resources
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Cheryl Ortiz, Special Agent in Charge
New Jersey
@DEANewJerseyDiv
November 29, 2012
Contact: Kenneth M. Heino
Phone Number: (571) 362-6616
For Immediate Release

Manhattan U.S. Attorney Announces Charges Against 10 Individuals In Multi-Million Dollar Internet Pharmacy Fraud Scheme Two Pharmacists Were Allegedly Paid At Least $13 Million By Bogus Online Pharmacy Operators For Filling Invalid Prescriptions Issued By

NEWARK, N.J. - Robert G. Koval, the Acting Special Agent in Charge of the New Jersey Division of the Drug Enforcement (DEA) and Preet Bharara, the United States Attorney for the Southern District of New York, today announced charges against two pharmacists, Peter J. Riccio and Lena Lasher; three physicians, John Nicholas Burling, Robert P. Imbernino, and Edmund S. Kaplan; and five website operators, Timothy Kear, Christopher Riley, Adam Risolia, Gergana Chervenkova, and Paul Gryszkiewicz, for their alleged participation in a multimillion dollar Internet pharmacy fraud scheme. The alleged scheme involved the sale and distribution of controlled and non-controlled substances to customers across the United States without valid prescriptions.

Nine of the defendants were arrested this morning and will be presented in federal court later today. Riccio, Lasher, Kear, and Gryszkiewicz will appear in Manhattan federal court, and Kaplan and Imbernino will both appear in the Central District of California. Burling, Riley, and Risolia will make their initial court appearances in the districts of South Carolina, Maryland, and (Southern), respectively. Chervenkova, a Bulgarian citizen based in Bulgaria, remains at large. In addition to the arrests, multiple search warrants were executed and bank accounts seized in connection with today’s charges.

Manhattan U.S. Attorney Preet Bharara stated: “As alleged, this multi-million dollar Internet pharmacy pill scheme involved pharmacists and doctors who placed cash over care by partnering with corrupt website operators to peddle massive quantities of addictive pain pills without valid prescriptions. We will not tolerate the violation of laws and regulations governing the pharmaceutical industry, and today’s arrests underscore our ongoing commitment to pursuing those who illegally put profit over public health and safety.”

DEA Acting Special Agent in Charge Robert G. Koval stated: “This allegedly illicit trafficking organization foolishly used the internet to further their illegal activities. This operation was not just another medical product source like a local neighborhood pharmacy, but rather an allegedly widespread, concealed international criminal enterprise that used the cover of the internet to commit fraud and drug trafficking.”

The following allegations are based on the Indictment unsealed today in Manhattan
federal court:

Background

Riccio is a licensed pharmacist who operated one pharmacy in New Jersey and two in Pennsylvania. Lasher was the Pharmacist-in-Charge at the Pennsylvania pharmacies. Burling, Imbernino, and Kaplan are licensed physicians located in South Carolina, California, and New York, New York, respectively. Kear, Riley, Risolia, Gryszkiewicz, Chervenkova, and (the “Website Operators”), operated websites that allowed customers to order pain medication without the valid prescriptions required by (the “Prescription Websites”). The prescriptions were written by Burling, Imbernino, Kaplan, and others, and then filled by Riccio and Lasher, and others.

The Internet Fraud Scheme

From 2010 until November 2012, customers seeking certain prescription pain medications including, Fioricet, Soma, Ultram, and (“Prescription Drugs”), which are highly addictive, would visit one of the Prescription Websites where they could choose the Prescription Drugs they wished to order. The Prescription Websites often contained misrepresentations regarding the issuance of the prescriptions. For example, a posting on one Prescription Website said that Prescription Drugs would not be dispensed before the customer consulted with the Prescription Website’s “U.S. Licensed Physician.” These consultations did not occur.

In order to get their prescriptions filled, Prescription Website customers were only required to complete an online medical questionnaire in which they were asked a series of questions regarding their medical history. The questionnaires often contained “yes” or “no” questions that were already marked with the correct answers to ensure that the customers were not disqualified from getting their prescriptions filled. Following the customer’s order and completion of the medical questionnaire, the Website Operators would transmit the questionnaire to Burling, Imbernino, Kaplan, and other doctors, who would issue a prescription without first conducting an in-person medical examination, reviewing medical records, or otherwise verifying any of the information provided by the customer, who often did not live in the same state as the doctor. Once issued by the doctor, the prescription was sent to a pharmacy, including the three operated by Riccio, to be filled. Riccio and/or Lasher would then fill or cause others to fill the prescriptions and then mail or deliver the Prescription Drugs to customers, including customers in the Southern District of New York.

Kear, Riley, Risolia, Chervenkova, Gryszkiewicz, and others paid the doctors who issued the prescriptions and the pharmacists who filled them via domestic and international wire transfers. During the course of the scheme, bank accounts controlled by Burling, Imbernino, and Kaplan received hundreds of thousands of dollars from Website Operators, including from bank accounts located in Cyprus, Hong Kong, and Israel. Bank accounts controlled by Riccio and/or Lasher received in excess of $13,000,000 from Website Operators.

. This case has been assigned to U.S. District Judge Naomi Reice Buchwald.

Mr. Bharara praised the investigative work of the DEA’s New Jersey Division. He also thanked the Internal Revenue Service-Criminal Investigation agents who are part of Homeland Security Investigation’s El Dorado Task Force, the Food and Drug Administration’s Office of Criminal Investigations, the United States Postal Inspection Service, the Department of Justice’s Office of International Affairs, and INTERPOL for their assistance in the investigation, which he noted is ongoing.

The prosecution is being handled by the Office’s Narcotics Unit. Assistant U.S. Attorneys Timothy D. Sini, Daniel C. Richenthal, and Ian McGinley are in charge of the prosecution. Assistant U.S. Attorney Andrew Goldstein is in charge of asset forfeiture related to the prosecution.

The charges contained in the Indictment are merely accusations, and the defendants are presumed innocent unless and until proven guilty.


nj112912_pharmacy.pdf
  • Facebook
  • Twitter
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Drug Prevention
    • Law Enforcement
    • Diversion Control Division
    • News
  • Careers
    • Overview
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
  • Resources
    • Drug Information
    • Employee Assistance Program
    • Equal Opportunity Employer
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
  • Policies
    • Accessibility, Plug-ins & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster